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Abstract Cyclooxygenase 2 (COX2), a key regulatory
enzyme of the prostaglandin/eicosanoid pathway, is an
important target for anti-inflammatory therapy. It is highly
induced by pro-inflammatory cytokines in a Nuclear factor
kappa B (NFjB)-dependent manner. However, the
mechanisms determining the amplitude and dynamics of this
important pro-inflammatory event are poorly understood.
Furthermore, there is significant difference between human
and mouse COX2 expression in response to the inflammatory
stimulus tumor necrosis factor alpha (TNFa). Here, we report
the presence of a molecular logic AND gate composed of two
NFjB response elements (NREs) which controls the
expression of human COX2 in a switch-like manner. Com-
bining quantitative kinetic modeling and thermostatistical
analysis followed by experimental validation in iterative
cycles, we show that the human COX2 expression machinery
regulated by NFjB displays features of a logic AND gate.
We propose that this provides a digital, noise-filtering
mechanism for a tighter control of expression in response to
TNFa, such that a threshold level of NFjB activation is
required before the promoter becomes active and initiates
transcription. This NFjB-regulated AND gate is absent in the
mouse COX2 promoter, most likely contributing to its dif-
ferential graded response in promoter activity and protein
expression to TNFa. Our data suggest that the NFjB-regu-
lated AND gate acts as a novel mechanism for controlling the
expression of human COX2 to TNFa, and its absence in the
mouse COX2 provides the foundation for further studies on
understanding species-specific differential gene regulation.
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Abbreviations
COX1 Cyclooxygenase 1
COX2 Cyclooxygenase 2
hCOX2 Human cyclooxygenase 2
mCOX2 Mouse cyclooxygenase 2
TNFa Tumor necrosis factor alpha
NFjB Nuclear factor kappa B
NRE NFjB response element
Gluc Gaussia luciferase
pGluc Plasmid encoding Gluc
CRE Cis-regulatory elements
Introduction
Inflammation is a part of the immune system’s response to
infection and injury. The usual outcome of an inflammatory
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cellular response is its successful resolution and repair
of tissue damage, whereas persistence and dysfunction of
the inflammatory response has been implicated in the
pathogenesis of diseases such as arthritis, cancer, neuro-
degenerative and cardiovascular diseases [1].
Key players in the generation of the inflammatory
response are the cyclooxygenase enzymes COX1 and
COX2, which catalyze the conversion of arachidonic acid
into pro-inflammatory prostaglandins and trigger the pro-
duction of other pro-inflammatory chemokines and
cytokines [2, 3]. COX1 is constitutively expressed in most
tissues and is involved in cellular housekeeping functions
[4], while the inducible isoform COX2 is expressed in
response to inflammatory stimuli such as TNFa [5]. Con-
sequently, a therapeutic strategy for inflammatory diseases
has involved the inhibition of COX, specifically COX2 [3]
(although adverse side effects have led to the withdrawal of
selective COX2 inhibitors [6]). Anti-inflammatory candi-
date drugs are usually developed and tested in mouse
models but have very poor success rates when moved to
clinical trials [7]. A recent review of mouse models of
inflammatory diseases has found no correlation between
the responses in mouse models and human diseases [7].
Thus, COX2 inhibitors, which work well in mouse, can be
unfavorable in humans.
Our work has focused on understanding the mechanisms
regulating induced COX2 expression at the level of gene
transcription. COX2 is regulated by a diverse group of
transcription factors such as AP1, CRE, HIF, SP1 and
STAT [8–11], but most importantly it is highly induced by
pro-inflammatory stimulus and activated by NFjB [12].
Indeed, the human COX2 promoter was shown to contain
two NFjB response elements (NREs) bound by the cano-
nical NFjB subunits p50 and p65 [11, 13–15]. In the
mouse COX2 promoter, only 1 NRE has been identified
[16], suggesting a different regulation. The mechanisms
determining the amplitude and dynamics of the NFjB-
mediated regulation of COX2 expression are poorly
understood. Given that NFjB is involved in the transcrip-
tion of a wide variety of genes [17–19], some of which
containing several NREs in their promoters, a key question
has been how it is involved in the specific activation of
these genes and the control of their activation amplitudes
and dynamics. TNFa was shown to induce p65 oscillations
[20, 21] in a concentration-dependent manner [22] and a
genome-wide analysis of NFjB binding sites in the human
genome showed that clusters of NREs increased gene
transcription in response to an increasing gradient of NFjB
concentration. This analog transcriptional response is pre-
dicted to become switch-like or digital when the binding
cooperativity among the NREs increases [23].
In this study, we used a combination of quantitative
kinetic modeling and experimental validation to describe a
novel mechanism for controlling the expression of human
cyclooxygenase 2 (hCOX2): a molecular logic AND gate
composed of two NREs acting in tandem to give a switch-
like property to hCOX2 expression. We also report that this
logic gate is absent in the mouse COX2 promoter, which
instead produced an analog response to NFjB. Thus, our
results demonstrate an additional level of complexity in the
specific gene activation by NFjB in different species.
Materials and methods
Cell culture
Human HEK293 and HT29 and mouse MEF cells were
cultured in DMEM high-glucose medium supplemented
with 10 % FCS and 100 U/ml penicillin–streptomycin in a
5 % CO2 humidified incubator.
Western blot analysis
To prepare whole cell extracts, cells were lysed with RIPA
buffer, centrifuged (14,000 rpm, 15 min, 4 C) and the
supernatant stored at -20 C. For the preparation of
nuclear and cytoplasmic extracts, cells were lysed in buffer
A (10 mM HEPES pH 8, 1.5 mM MgCl2, 10 mM KCl,
200 mM sucrose, 0.5 mM DTT, 0.25 % NP-40 and 19
PIC), centrifuged (12,000 rpm, 1 min, 4 C), the super-
natant containing the cytosolic extract was stored at
-20 C. The nuclear pellet was washed again in buffer A,
suspended in buffer C (20 mM HEPES pH 8, 420 mM
NaCl, 0.2 mM EDTA, 1.5 mM MgCl2, 0.5 mM DTT,
25 % glycerol), incubated for 30 min on ice and pelleted
again, the supernatant containing the soluble nuclear pro-
teins was stored at -80 C. Protein concentrations were
quantified using a Lowry assay and normalized accord-
ingly. Samples were separated by SDS-PAGE and
immunoblotted using the following antibodies: goat COX2
(1:1,000, Santa Cruz, sc-1745), mouse b-actin (1:10,000;
Sigma, A5441), rabbit p65 (1:1,000, Santa Cruz, sc-372),
rabbit lamin A/C (1:1,000; Cell Signaling, 2032). Se-
condary antibodies, anti-mouse IgG HRP conjugate
(1:1,000, Promega) and anti-rabbit IgG HRP conjugate
(1:1,000, Promega) were used. Development was per-
formed with the Detection kit Pierce ECL Western
Blotting Substrate (Thermo Scientific). Stripping buffer
was used to allow for the detection of all the above-men-
tioned antigens on the same membrane.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were per-
formed as previously described with some modifications
2432 L. K. Nguyen et al.
123
[15]. HEK293 and MEF cells fully confluent on T175
flasks were conditioned to 10 ng/mL TNFa for 45 min.
Cells were fixed with 1 % formaldehyde in 10 mL fresh
media for 10 min with agitation. Fixation was stopped with
125 mM glycine treatment for 5 min. Cells were scrapped
with 1 mM PMSF in PBS, pelleted and resuspended in
1 mL ChIP buffer A (100 mM Tris pH 9.4, 10 mM DTT,
PIC and 1 mM PMSF), after 10 min incubation with
agitation cells were pelleted and resuspended in ChIP
buffer D (10 mM Tris pH 8.0, 1 mM EDTA, 0.5 % em-
pigen, PIC and 1 mM PMSF), and incubated on ice for
30 min. Samples were subjected to sonication (Bioruptor),
cell debris was pelleted (14,000 rpm, 5 min, RT) and
400 lL of the supernatant containing the shred chromatin
with an average size of 500–1,000 bp was mixed with
900 lL of ChIP dilution buffer (20 mM Tris pH 8,
150 mM NaCl, 2 mM EDTA, 1 % Triton, 1 mM PMSF)
and pre-cleared with 50 lL of protein A/salmon sperm
beads (16–157, Millipore) previously blocked with BSA in
ChIP dilution buffer, and incubated overnight with agita-
tion at 4 C. Beads were centrifuged and the chromatin was
quantified using a NanoDrop (Thermo Scientific), 60 lg of
chromatin was diluted in ChIP dilution buffer to a final
volume of 650 lL, 10 lL was taken as input, 1 lg of p65
antibody (rabbit, Santa Cruz, sc-372) or IgG control anti-
body (rabbit, Millipore, PP64B) was added and incubated
overnight at 4 C with agitation. This was followed by
centrifugation and the supernatant from the spin step con-
taining the chromatin:p65 immuno-complexes was
incubated with 50 lL of protein A/salmon sperm beads
(previously blocked with BSA in ChIP dilution buffer) for
2 h at 4 C with agitation. Beads were washed twice with
RIPA buffer (50 mM HEPES pH 7.8, 140 mM NaCl, 1 %
Triton X-100, 1 mM EDTA, 0.1 % sodium deoxycholate
and 0.1 % SDS) with 15-min incubation periods at 4 C
with agitation. This was followed by washing steps with
high salt RIPA (RIPA supplemented with 350 mM NaCl),
LiCl buffer (20 mM Tris pH 8.0, 250 mM LiCl, 0.5 %
IGEPAL CA-360, 1 mM EDTA, 0.5 % sodium deoxy-
cholate and 0.5 mM PMSF) and finally twice with TE
buffer (10 mM Tris, 1 mM EDTA, pH 7.4). Immuno-
complex elution was performed by adding 250 lL of
elution buffer (1 % SDS, 0.1 M NaHCO3) to the cen-
trifuged beads and heated with shaking at 65 C. 240 lL of
the supernatant was recovered and this step was repeated.
470 lL of elution buffer was now added to the input
samples, and treated as the ChIP samples from now on.
Samples were treated with RNAse A for 30 min at 37 C.
Crosslinks were reversed by incubating the samples over-
night at 65 C. Samples were than treated with proteinase
K (42 C, 2 h). The DNA was than isolated by phenol/
chloroform precipitation, and resuspended in 60 lL nu-
clease free water. Purified DNA (3 lL) was amplified
using human COX-2 promoter primers (NRE1: forward
50-GGCAAAGACTGCGAAGAAGA-30, reverse 50-AAAA
TCGGAAACCCAGGAAG-30; NRE2: forward 50-CCTCG
ACCCTCTAAAGACGTA-30, reverse 50-AGCCAGTTCT
GGACTGATCG-30) using a thermocycler program (94 C
for 3 min; then 36 cycles of 94 C for 20 s, 60 C for 30 s,
and 72 C for 30 s; then a hold cycle of 10 C). Samples
were run on a 2 % agarose gel using ethidium bromide to
visualize a 150-bp product for NRE1 and a 165-bp product
for NRE2. For the mouse NRE site, we had technical dif-
ficulties in amplifying a single PCR product (data not
shown), thus we used Taqman chemistry, which combines
specific primers and probes to prevent the formation of
unspecific products and primer dimers. Thus, chromatin
precipitation analysis of the mouse NRE site was per-
formed using quantitative-reverse-transcription PCR
(qPCR), and the results are shown as fold change to the
unstimulated p65 precipitated chromatin, after normaliza-
tion to the input samples. The sequences for the Taqman
reagents are: forward 50-AGACTGCGCCCCAGT-30,
reverse 50-CCGGGATCTAAGGTCCTAACTAAGG-30,
probe 50-GGGAGAGGTGAGGGGAT-30). The following
program was used 50 C for 2 min, followed by 95 C for
10 min; then 39 cycles of 95 C for 15 s followed by 60 C
for 60 s, in the 7900HT Fast Real-Time PCR System (Life
Technologies).
Transient transfections and Gaussia luciferase assay
All transfections were performed using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s proto-
col. The empty vector used for cloning is the pGluc vector
(NEB) driven by a minimal promoter [11]. The pGluc-
COX2 Gaussia luciferase vector contains the sequence -4
to -631 of the human COX2 gene which includes two
NFjB response elements (NREs) [11]. The pGluc-mCOX2
vector was made by inserting the sequence -441 to -116
of the mouse COX2 gene which includes one NFjB re-
sponse element [16]. The pGluc-IL6 Gaussia luciferase
vector was made by inserting the sequence ?1 to -225 of
the human interleukin-6 gene which includes one NFjB
response element only [24]. The pGluc-2xIL6 Gaussia lu-
ciferase vector was made by inserting two copies of the
sequence ?1 to -225 of the human IL6 promoter to create
an artificial OR gate. The sequence of the inserts used is
provided in Supplementary Figures S1, S2, S5 and S6.
Mutations to remove the NREs were introduced by site-
directed mutagenesis. Concentration of plasmids used for
transfection was 100 ng/100,000 cells unless otherwise
stated. For the promoter concentration experiments, to
maintain equal concentration of DNA transfected, we have
used the empty vector plasmid DNA to buffer the trans-
fection mix. Gaussia luciferase activity was measured
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using the Biolux Gaussia luciferase Flex Assay kit (NEB)
in a plate reader (Synergy HT, Biotek).
Analysis of transcriptional activity
A mathematical expression for the transcriptional activity r
as a function of the TF concentration can be derived using a
thermostatistical approach. It is useful to rescale the con-
centration of the relevant TF with its dissociation constant.
Thus, a dimensionless, relative concentration variable
[TF]rel is obtained [25]. For the 1-site model and for the
AND gate, the transcriptional activity as a function of
[TF]rel reads as [26].
r TF½ rel
  ¼ r0 1þ Asatc½TF
n
rel
1þ c½TFnrel
with exponents n = 1 for the 1-site model and n = 2 for
the AND gate. Here, r0 is the baseline activity for zero TF
concentration. The transcriptional activities r(X) and r0 are
measured in arbitrary units. The parameters c and Asat are
lump parameters that are composed of certain chemical
binding energies [25, 26]. The parameter Asat has a simple
interpretation. The product r0Asat is the saturation
transcriptional activity. The predicted fold change can be
computed as well. To this end, the formula is divided by
the baseline activity.
Fold change ¼ 1þ Asatc½TF
n
rel
1þ c½TFnrel
We see that Asat corresponds to the fold change for
saturation. Furthermore, the expression for the transcriptional
activity can be cast into the form of a Hill function like
r TF½ rel
  ¼ bþ Rmax ½TF
n
rel
d þ ½TFnrel
with r0 = b, c = 1/d, and Asat = (Rmax ? b)/b. Although
the relationship between the stimulus X (e.g., TNFa) and the
relative transcription factor concentration [TF]rel has to be
modeled separately (e.g., by means of a linear or nonlinear
mapping X ? [TF]rel), the fact that in the thermostatistical
model the exponent n is higher for the AND gate than for
the 1-site model suggests that the AND gate exhibits more
switch-like behavior relative to the promoter with a single
binding site. In doing so, the analytical thermostatistical
approach is consistent and complementary to the numerical
kinetic modeling approach described below.
Quantitative kinetic modeling of promoter activity
mediated by transcriptional factors
To quantitatively analyze and predict steady-state dynam-
ics of the COX2 gene expression under different modes of
regulation by a transcriptional factor (e.g., NFjB), we
developed three general kinetic models that describe: (1) a
promoter that is regulated by a transcriptional factor
through a single TF-Promoter binding site; (2) a promoter
regulated by a transcriptional factor through two TF-Pro-
moter binding sites following a OR gate and (3) a promoter
regulated by a transcriptional factor through two TF-Pro-
moter binding sites following an AND gate regulation. For
convenience, we will refer to these models as the ‘‘1-site’’,
‘‘2-site OR-gate’’ and ‘‘2-site AND-gate’’ models, respec-
tively. These models are schematically illustrated in
Fig. 4a–c in the main text.
An optimal modeling strategy keeps the model simple,
yet biologically relevant and importantly capable of gen-
erating meaningful predictions. To this end, the models
formulated are kept to minimal details, containing several
biologically reasonable assumptions and simplifications:
(1) The 1-site model is straightforward. Binding of the TF
to its promoter follows mass-action kinetic laws of simple
association/dissociation. We assume that the promoter
becomes active and transcription is ON as soon as the
binding site is occupied, and turned OFF when the TF
dissociates from the promoter. (2) In the 2-site models, we
assumed that binding between the TF and two sites occurs
independently: the association/dissociate rates between the
TF and either of the binding sites are the same when both
sites are initially unoccupied, or when one of them is
already occupied by the TF. In the OR gate model, tran-
scription is ON as long as at least one site is occupied
whereas in the AND gate model, transcription is ON only if
both sites are occupied.
Literature derived information on model parameters
NFjB p65 copies number has been measured in TNF-sti-
mulated T-leukemia cell lines to be 120,000 [27].
Assuming the cell volume to be that of a typical hepato-
cyte, which is about 4 9 10-12 L [28], the copies number
per cell is converted to concentration of about 50 nM.
Thus, we used this number for the concentration of the TF
in our models. Values of the association and dissociate
rates of transcriptional factor binding to its DNA-biding
site are rarely reported for mammalian systems; however,
in bacteria such as E. coli these have been measured for the
lac promoter and its TF regulators (repressor and activator)
which is about 0.0027 nM-1 s-1 for association rate [29]
and about 0.0023 s-1 for dissociation rate [30]. For our
simulations, we used association rate = 0.002 nM-1 s-1
and dissociation rate = 0.002 s-1 in the 2-site models, and
0.02 s-1 for dissociation rates in the 1-site model as rea-
sonable values.
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Model reactions and ODEs
2-site ODE model
ODEs
dTFP00 tð Þ
dt
¼ kf1P00 tð ÞTF tð Þ  kf3P00ðtÞTF tð Þ
 kr2TFP10 tð Þ þ kr3TFP01 tð Þ
dP00ðtÞ
dt
¼ kf1P00 tð ÞTF tð Þ  kf3P100 tð ÞTFðtÞ
 kr2TFP10 tð Þ þ kr3TFP01
dTF tð Þ
dt
¼ kf1P00 tð ÞTF tð Þ  kf2TF tð ÞTFP10 tð Þ
 kf3P00 tð ÞTF tð Þ  kf4TF tð ÞTFP01 tð Þ
þ kr1TFP10 tð Þ þ kr2TFP11 tð Þ þ kr3TFP01 tð Þ
þ kr4TFP11 tð Þ
dTFP01 tð Þ
dt
¼ kf3P00 tð ÞTF tð Þ  kf4TF tð ÞTFP01 tð Þ
 kr3TFP01 tð Þ þ kf4TFP11 tð Þ
dTFP10 tð Þ
dt
¼ kf1P00 tð ÞTF tð Þ  kf2TF tð ÞTFP10 tð Þ
 kr1TFP10 tð Þ þ kr2TFP11 tð Þ
dTF P11ðtÞ
dt
¼ kf2TFP10 tð Þ þ kf4TF tð ÞTFP01 tð Þ
 kr2P11 tð Þ  kr4TFP11ðtÞ
1-site ODE model
Reactions
TFþ P0 
kr1
kf1
TFP1
ODEs
dP0 tð Þ
dt
¼ kr1TFP1 tð Þ  kf1P0 tð ÞTF tð Þ
dTF tð Þ
dt
¼ kr1TFP1 tð Þ  kf1P0 tð ÞTF tð Þ
dTFP1 tð Þ
dt
¼ kf1P0 tð ÞTF tð Þ  kr1TFP1 tð Þ
The same parameter values as given in Table 1 are used for
the 1-site model.
Hill function fitting and Hill coefficient calculation
The steepness of a dose–response curve is often indicated
by the Hill coefficient value resulting from fitting the curve
with a Hill function [31]. The following Hill function was
used for fitting dose–response data curves (Supplementary
Figure S3):
Hill function ¼ bþ Rmax x
H
xH50 þ xH
where b is the offset level, Rmax is the maximal response,
x50 is the half-maximal threshold and H is the Hill coeffi-
cient which indicates strength of the switch. Fitting was
implemented with the NonlinearModelFit function in
Mathematica 8.
Sequence alignment
Sequences and species alignment for the COX2 promoters
were obtained from the University of California Santa Cruz
Genome Browser [32].
Reagent
Tumor necrosis factor a (TNFa) was obtained from Sigma
(Ireland).
Statistical analysis
All experiments were carried out a minimum of n = 3
independent times unless otherwise indicated and data are
expressed as the mean ± SEM. Statistical significance was
calculated by Student’s t test for the comparison of two
datasets or one-way ANOVA followed by Bonferroni’s
multiple comparison test (Microcal Origin Lab 7.5; Origin
Lab) for more than two datasets. P\ 0.05 was considered
statistically significant.
Table 1 Reactions and parameter values of the 2-site models
Reactions Parameter values
TFþ P00 
kf1
kr1
TFP10 kf1 = 0.002
kr1 = 0.002
TFþ P10 
kf2
kr2
TFP11 kf2 = 0.002
kr2 = 0.002
TFþ P00 
kf3
kr3
TFP01 kf3 = 0.002
kr3 = 0.002
TFþ P01 
kf4
kr4
TFP11 kf4 = 0.002
kr4 = 0.002
The association and dissociation kinetic rates (k) used have units of
nM-1 s-1 and s-1, and all concentration of all molecular species have
unit of nM. TF refers to transcription factor. P refers to the promoter,
with 00 referring to bound TF on both binding sites, 01 and 10 re-
ferring to occupancy of either the first or the second binding site and
11 referring to occupancy of both binding sites. Initial conditions:
TF(0) = 10, P0(0) = 50, all remaining species are zero
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Results
Species differences between human and mouse COX2
protein expression
The inflammatory stimulus TNFa induces nuclear local-
ization of p65, one of the main subunits of NFjB [17, 18]).
We indeed observe that this response is linear in both
mouse MEF cells and human HT29 cells exposed to
increasing concentration of TNFa (Fig. 1a, b). The nuclear
localization of p65 resulted in a proportional increase in
COX2 protein expression in mouse cells, but not in the
human cells (Fig. 1c, d; Supplementary Figures S3A and
B), suggesting a species difference in COX2 expression in
response to TNFa downstream of p65 nuclear transloca-
tion. Thus, we investigated the promoter of COX2 to
identify possible differences in cis-regulatory response
elements.
Analysis of the human COX2 promoter reveals
an additional NFjB response element
It has been shown that a single nucleotide can determine
which co-factors are recruited to the NFjB response ele-
ment (NRE) [33], and speculated that species-specific
differences in the COX2 production between mice and
A B
C D
Fig. 1 TNFa-induced nuclear
localization of p65 and COX2
protein expression in human and
mouse. a, b Nuclear p65 in
human HT29 and mouse MEF
cells stimulated with TNFa
(0–100 ng/ml) for 1 h (n = 3,
data shown as normalized to
lamin A/C). c, d Expression of
COX2 protein in human HT29
and mouse MEF cells
stimulated with TNFa
(0–100 ng/ml) for 6 h (n = 3,
data shown as normalized to b-
actin)
2436 L. K. Nguyen et al.
123
human could be caused by differences in the NRE element.
The mouse COX2 (mCOX2) promoter was previously
shown to contain only 1 functional NFjB response element
(NRE; [16]), which is conserved among species (termed
NRE1; Fig. 2a). Thus, we considered the hypothesis of
different co-factor recruitment unlikely. Interestingly,
alignment of the COX2 promoters for different species
reveals that the second NRE (termed NRE2) present in
humans is conserved only among primates but not in other
species such as rodents (Fig. 2a). Chromatin immunopre-
cipitation experiments in human HEK293 and mouse MEF
cells show that there is increased p65 bound to the two
human NRE sites (Fig. 2b) and to the single mouse NRE
site (Fig. 2c) upon stimulation with tumor necrosis factor
alpha (TNFa). Therefore, we decided to determine whether
the presence of the second, active, NRE element in the
human promoter could be responsible for the species-spe-
cific differences in COX2 regulation. We reason that the
function of the two NREs in the human COX2 promoters
can be revealed by examining the response of the pro-
moters to increasing concentration of TNFa.
We next compare the transcriptional activities of the
human COX2 promoter to the mouse equivalent (details of
the sequence are shown in Supplementary Figures S1–S2).
These experiments are performed in HEK293 cells, so that
the responses of the human and mouse promoters to the
same inflammatory stimulus can be compared. Our data
indicate that the response from the mouse COX2 promoter
is linear (Fig. 2d; Supplementary Figure S3C), whereas the
response from the human COX2 is switch-like (Fig. 2e;
Supplementary Figure S3D). Taken together, the pattern of
the protein expression shows good correlation with the
promoter activity (Fig. 1), indicating that the NFjB-regu-
lated promoter has a strong influence on the COX2 protein
expression.
An AND gate regulating the human cyclooxygenase 2
expression
To determine the contribution of each NRE to hCOX2
expression, we have generated mutants of the NREs of the
hCOX2 promoter and find that the promoter activities
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Fig. 2 Analysis of the human and mouse COX2 promoters. a Cross-
species sequence alignment of the COX2 promoters shows that the
NRE1 is conserved among species analyzed, but the NRE2 (in red) is
only observed among primates (including human) and absent in
rodents (including mouse). b Chromatin immunoprecipitation analy-
sis shows binding of p65 to both NREs on the hCOX2 promoter in
HEK293 cells stimulated with TNFa (10 ng/ml). The products of the
PCR reactions where run on an agarose gel and a representative
picture from four independent experiments are shown. c Chromatin
immunoprecipitation analysis shows binding of p65 to the NRE on
the mCOX2 promoter in MEF cells stimulated with TNFa (10 ng/ml)
(n = 3). Quantification of p65 binding to the mouse NRE was
performed using the Taqman system for qPCR, results are shown as
fold change to the p65-immunoprecipitation of unstimulated cells
after normalization to input controls. TNFa-induced luciferase
activity under the control of mouse (d) and human (e) COX2
promoters expressed in HEK293 cells (shown as fold activation over
unstimulated; n = 4)
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resulting from either mutation of single sites or dual
mutations in both sites are similarly significantly lower
than the activity of the wild type in response to TNFa
(Fig. 3a). These activity responses can be represented on a
truth table (Fig. 3b) which displays how the output (1 for
promoter activity ‘‘ON’’ and 0 for promoter activity
‘‘OFF’’) relates to various combinations of the inputs (1 for
‘‘presence’’ and 0 for ‘‘absence’’ of the response elements).
The table shows that promoter activity is observed only
when both NREs are intact. Consequently, the regulation of
the hCOX2 promoter is consistent with the functioning of
an AND gate. In the general case, the output of an AND
gate assumes two distinct states that may differ in meaning
(like ‘‘on’’ and ‘‘off’’) or correspond to two different values
on a discrete (like ‘‘0’’ and ‘‘1’’) or continuous (like -5 and
?5 V) scale. Moreover, the AND gate exhibits two input
ports and one of the two output signals can only be ob-
served when both input ports are activated. In all other
cases, the other output signal can be observed. In our
context, the two output states correspond to low and high
levels of promoter activity, while the two input ports cor-
respond to the two NREs. Finally, note that also at a higher
concentration of TNFa (Supplementary Figure S4) the
promoter response is still consistent with the functioning of
an AND gate.
Mathematical models of NREs-regulated
transcriptional activity
To explore the functional and dynamic property of our
proposed logic AND gate, we constructed a set of quanti-
tative kinetic models of promoter activity based on the
binding of a transcription factor (TF) to a promoter con-
taining either one binding site (TFBS, Fig. 4a), two sites
with an OR gate (Fig. 4b) or two sites joined as an AND gate
(Fig. 4c). Details of the model development including
model equations and parameter values are given in
the ‘‘Materials and methods’’ section. Model simulations
predict that, at a given concentration of the input TF, the
promoter activity increases following a monotonic, satur-
ating pattern in response to increasing concentration of the
promoter in the 1-site or 2-site OR gate models (Fig. 4d, e).
However, for the 2-site AND gate model, as in the case of
our hCOX2 expression system, the transcriptional activity is
predicted to follow a distinct bell-shaped, biphasic depen-
dence on the promoter concentration (Fig. 4f). Increasing
the promoter concentration enhances the promoter activity
at lower concentrations, while a further increase beyond an
optimal level instead attenuates the activity. Mechanisti-
cally, a very high concentration of the promoter will
sequester individual molecules of the TF to either of its
binding sites forming TF-promoter complexes that are in-
complete, i.e., having just site 1 or site 2 occupied by the TF
(no transcriptional activity), but only few complexes with
both sites occupied (transcriptionally active). This effect is
generally known as the prozone effect [34], which has been
previously reported for scaffold proteins [35].
To further show that the predicted bell-shaped feature is
a robust property of the 2-site AND gate model, we carried
out unbiased simulations where the model kinetic rate
constants were allowed to randomly vary within wide
ranges of physiologically plausible values. For 1,000 ran-
dom parameter sets simulated, the 2-site OR gate model
only showed monotonic, saturating dose–response curves
for the promoter activity across simulated sets (Supple-
mentary Figures S7A). On the contrary, the same analysis
for the 2-site AND gate model consistently displayed the
bell-shaped activity dependence across the sets despite
having variability in the activity amplitude and optimal
peak (Supplementary Figures S8C). Calculating the mean
curve and curves within one standard deviation further
confirmed the robustness of the predicted bell-shape
response (Supplementary Figs. 7B vs. 7C). Taken together,
these ensemble simulations demonstrate that the prozone
effect is an exclusive and robust feature of the 2-site AND
gate model.
A B
Fig. 3 The two NFjB response elements of COX2 form a functional
logic AND gate. a Transcriptional activity of hCOX2 wild-type
promoter or mutants in response to TNFa (shown as fold activation
over unstimulated; n = 4). b Truth table showing the relationship
between promoter activity (1 = active due to NFjB, 0 = basal) and
presence (1) or absence (0) of NRE for wild-type and mutants hCOX2
promoter. Significant differences (p\ 0.05) are denoted by asterisk
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To experimentally test the predicted prozone effect for
various expression systems, we use a sequence from the
interleukin-6 promoter which was previously shown to
contain only one functional NRE [24] as example of the
1-site model (Fig. 4g, detail of the sequence used is shown
in Supplementary Material). We next duplicate this
sequence to create a promoter with two binding sites for
NFjB (Fig. 4h; detail of the sequence used is shown in
Supplementary Material), exemplifying the 2-site model.
Using a constant stimulus level of TNFa and transfecting
increasing amount of plasmid DNA encoding the different
promoter constructs, promoter activity responses measured
for the three cases agree well with model predictions, with
a biphasic pattern observed only for the AND gate hCOX2
promoter (Fig. 4g–i). Thus, we show, using mathematical
modeling and experimental validation, that the two NREs
on the hCOX2 promoter form a functional AND gate
which requires both NREs to be occupied by NFjB to be
active.
Mathematical prediction of NREs-regulated COX2
activity in mouse and human
Our mathematical model predicts that a promoter with a
single TFBS is likely to produce a linear increase in pro-
moter activity (Fig. 5a), whereas one with two sites that
function like an AND gate will instead produce a
sigmoidal, switch-like response (Fig. 5b). To test if this
prediction is robust and that the sigmoidal response is a
more characteristic property of the 2-site AND gate model
compared to the 1-site model, we carried out similar
ensemble simulations with large number of randomized
parameter sets as described in the previous section. We
varied the kinetic rate constants in both models over wide
ranges of values within typical physiological intervals and
for each parameter set, we quantified the switchness of the
dose–response curve by calculating the corresponding Hill
coefficient (Fig. 5c–e). The 2-site AND gate model gen-
erally displays a much more switch-like activity response
compared to that of the 1-site model. This is further cor-
roborated by the quantified Hill coefficient, which is
statistically significantly higher for the 2-site AND gate
than the 1-site model (Fig. 5e). Taken together, the model
predictions for the COX2 promoter activity show good
correlation with the experimental observed promoter
activity (Fig. 2c, d), indicating that the human COX2 is
likely to be regulated by the NFjB-regulated AND gate in
its promoter.
When there is a graded signal output to an input, the cell
requires a large change in the inflammatory stimulus
(input) to achieve a maximum expression of COX2 (signal
output; Fig. 5f, red line). However, if the output/input
curve is switch-like, maximal COX2 is rapidly expressed in
response to a much smaller change in the inflammatory
A B C
D E F
G H I
Fig. 4 Mathematical models of
promoter activity. Simplified
schemes showing binding of
TFs on promoters with 1
transcription binding site
(TFBS) (a), or 2 TFBS arranged
as OR (b) or AND gates (c).
Promoter is either activated (1)
or not (0). d–f Mathematical
predictions of the transcriptional
activity for each scheme, at a
fixed concentration of TF but
varying concentration of
promoters. Model association/
dissociation rates used for
plotting panel (f) are 0.001 and
0.2, respectively. Values for
other panels are given in
‘‘Materials and methods’’. g–
i Experimental validation of
predictions using artificial
promoters or the hCOX2
promoter expressed in HEK293
cells in response to TNFa (1 ng/
ml). Data are shown as fold
activation over unstimulated
(n = 4–5)
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stimulus (Fig. 5f, blue line). Furthermore, the switch-like
behavior provides a minimum threshold for activation at
which the inflammatory stimulus needs to reach before
COX2 can be maximally expressed.
Discussion
Cyclooxygenase 2, a key regulatory enzyme of the
prostaglandin/eicosanoid pathway, is highly induced by
pro-inflammatory cytokines in an NFjB-dependent man-
ner. Here, we show that the presence of the NFjB-
regulated AND gate in the human COX2 promoter acts as a
noise filter such that a threshold of NFjB activation is
required before the promoter becomes active and initiates
transcription. While the AND gate uncovered for the
human COX2 promoter is composed of two response ele-
ments for NFjB, it is likely that other AND gates may exist
with multiple response elements for either the same tran-
scription factor or a combination of two or more different
transcription factors [33]. For example, there is an indica-
tion of similar regulatory mechanisms from the promoter
assays for the NFjB regulation of Receptor for Advanced
Glycation Endproducts (RAGE [36]) and C-X-C motif
chemokine 10 (CXCL10 [37]).
Boolean logic elements such as AND and OR gates have
been identified both at the level of cell signaling [38, 39]
and the genetic level [26, 40–42]. In these studies, typically
two different input signals have been considered repre-
senting either different pathways or different transcription
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Fig. 5 Digital noise filtering property of the AND logic gate in the
hCOX2 promoter. a, bMathematical predictions of the transcriptional
activity of the promoter with TFBS site (corresponding to mouse
COX2) or 2 TFBS arranged as an AND gate (corresponding to human
COX2). c–e Ensemble simulation of the 1-site model vs. 2-site AND
gate model. c Simulations of the 1-TFBS model for 100 random
parameter sets randomly drawn from the ranges (0.0001, 0.01) and
(0.001, 0.1) for association and dissociation kinetic rates, respectively.
Parameter units are given in Table 1. d Similar simulations as in c for
the 2-site AND gate model. e Comparison of level of switchness of the
dose–response curves (c, d) quantified as the fitted Hill coefficient for
1-site model vs. 2-site AND gate model. Significant differences
(p\ 0.05) are denoted by asterisk. f Comparison between a graded or
switch-like response: for a similar increase in output (from 10 to
90 %), a graded response (red line) requires a larger change in input
than for a switch-like response (blue line)
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factors. In contrast, we have developed our arguments in
analogy to electronic Boolean gates that feature spatially
separated input ports that receive the same kind of signals.
The two NREs are considered as two input ports at sepa-
rated locations that respond to the same kind of input in
terms of NFjB activation. Binding of the NFjB tran-
scriptional factor to only one of the two sites is analogous
to an electronic AND gate receiving a signal at only one of
its input ports. In this case, the COX2 expression system, as
well as the electronic case, responds as if no signal was
received at all and delivers a low, basal response. If
bindings to both NREs occur, then this scenario is com-
parable with an electronic AND gate that receives signals
at both input ports. In the COX2 as well as the electronic
gate, the regulatory machinery responds with an output
signal that is qualitatively and significantly higher than the
basal response. In other words, we may say that our
observations suggest a strong cooperative effect between
the two NRE sites. The cooperativity effect exists in the
sense that the two sites require one another to respond
appropriately to NFjB activation. While we have shown
that the two NREs of the human COX2 promoter confer an
AND gate-like behavior to the transcriptional response, we
are aware that a full explanation of how this behavior is
achieved will require further investigations, such as
detailed analysis of the sequence and nucleic acid tertiary
structure [43].
TNFa induces a similar linear nuclear localization of
p65 in both human HT229 and mouse MEF cells, but only
the human cell displayed a switch-like expression of COX2
protein. We thus propose that the absence of the NFjB-
regulated AND gate in the mouse COX2 promoter is most
likely responsible for its linear response in promoter
activity and protein expression to TNFa. Our data show
that the mouse COX2 is sensitive to a spectrum of TNFa
concentration, whereas the human COX2 has a narrower
range. The regulation of COX2 is complex and very likely
involves crosstalk with other transcription factors [8–11],
which may be affected by TNFa. However, in this paper,
we concentrate on TNFa-induced NFjB regulation of
COX2 only.
Our experimental evidence comes from measuring
transcriptional activity and protein expression as a popu-
lation of cells was exposed to TNFa. This measurement is
the average of the total population and we have assumed
that all the cells have responded to a similar fashion.
However, it is possible that the average measurement is
primarily due to a fraction of the cells in the population
which have responded, with the remaining unresponsive or
less responsive. Examining this possibility requires single
cell measurement for protein expression and potentially a
surrogate marker for transcriptional activity [44], which is
an area for future investigation.
Species-specific differential regulatory mechanisms of
gene expression, as demonstrated here for COX2, may
contribute to the recently reported discordance observed
between human and mouse models of inflammatory dis-
eases [7]. The study of these mechanisms will help us to
understand when the findings from biomedical research in
mouse models are relevant to human disease [45]. Several
examples of these mechanisms exist. For example, the
transcription factor ETS1 is responsible for the mouse
specific expression of the T cell factor Thy-1 in the thymus,
and its preferential recruitment to the proximal promoter of
human genes but not mice genes has been suggested to
contribute to the immune system differences between mice
and human [45]. Different patterns of histone methylation
and acetylation have also been found to be associated to the
species-specific expression of genes across several repre-
sentative tissues, indicating that epigenetic regulation is
also a key mechanism leading to differential gene expres-
sion in mice and human tissues [46]. In addition to the
differential binding of TF to the promoter and epigenetics
marks, differences in the cis-regulatory elements (CRE, TF
binding sites and associated sequences required for tran-
scription) can also contribute to species-specific expression
patterns of the same gene [47]. Species-specific differences
in gene expression can arise due to novel CRE, but also
through mutations in pre-existing CRE including inser-
tions, deletions, duplications and changes in the DNA
strand of the TF binding site [47]. Our work here identifies
the presence of an AND gate-like behavior composed of 2
NRE sites in the human COX2 promoter, that is absent in
the mouse promoter, as a novel regulatory mechanisms
leading to species-specific divergence in the expression of
this key inflammatory gene.
Candidate drugs are usually developed and tested in
mouse models, but have very poor success rates when
moved to clinical trials [7]. COX2 inhibitors have been
withdrawn due to major adverse effects [6]. Our results
suggest that the induction of COX2 in human is threshold
controlled, i.e., in the absence of sufficient inflammatory
stimulus, COX2 is not induced. It is possible in these cir-
cumstances that COX2 inhibitors instead target other
pathways non-specifically, potentially leading to the
reported adverse effects. Thus, we propose that the devel-
opment of future COX2 inhibitors should take into account
the threshold-controlled regulation of COX2 expression by
inflammatory stimulus and species-specific differences.
In conclusion, the logic AND gate comprised of the two
NREs characterized in this study represents a novel reg-
ulatory mechanism for the multitude regulation modes
exhibited by NFjB [18, 48]. Our data indicate that this
AND gate acts as a noise filter to tightly regulate the
expression of COX2. It is very likely that similar AND gates
may exist on other genes to regulate their transcription [33,
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36, 37] and our study provides the foundation for further
studies on understanding the regulation of genes with
switch-like expression [49–51]. Furthermore, we show that
COX2 expression is differentially regulated in human and
mouse, and attribute this difference to the presence of the
AND gate in its human promoter but absence in the mouse
homolog. These findings may explain the variance between
animal models of inflammatory diseases and differences to
human conditions and highlight the need for careful selec-
tion of appropriate substitute models to represent human
inflammatory diseases.
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